Study question: Does the oestrogen receptor isoform, ER46, contribute to regulation of 25 endometrial function? 26
receptors (ER66, ER46 and ERβ) was assessed by qPCR, western blot and 48 immunohistochemistry. Uterine Natural Killer (uNK) cells were isolated from first trimester 49 human decidua by magnetic bead sorting. Cell motility of uNK cells was measured by live cell 50 imaging: cells were treated with oestradiol (E2)-BSA (10nM equivalent), the ERβ-selective 51 agonist 2,3-bis (4-hydroxyphenyl)-propionitrile (DPN; 10nM) or vehicle control (DMSO). 52
Main results and the role of chance: ER46 was detected in proliferative and secretory phase 53 tissues and was the predominant ERα isoform in first trimester decidua samples. 54
Immunohistochemistry revealed ER46 was co-localised with ER66 in cell nuclei during the 55 proliferative phase but detected in both the cytoplasm and cell membrane of stromal cells in 56 the secretory phase and in decidua. Triple immunofluorescence staining of decidua tissues 57 identified expression of ER46 in the cell membrane of CD56-positive uNK cells which were 58 otherwise ER66-negative. Profiling of isolated uNK cells confirmed expression ER46 and 59 localised ER46 protein to the cell membrane. Functional analysis of isolated uNK cells using 60 live cell imaging demonstrated that activation of ER46 with E2-BSA significantly increased 61 uNK cell motility. 62
Limitations, reasons for caution: Expression patterns in endometrial tissue was only 63 determined using samples from proliferative and secretory phases. Assessment of first 64 trimester decidua samples was from a range of gestational ages which may have precluded 65 insights into gestation specific changes in these tissues. Our results are based on in vitro 66 responses of primary human cells and we cannot be certain that similar mechanisms occur in 67 situ. 68
Wider implications of the findings: E2 is an essential regulator of reproductive competence. 69
This study provides the first evidence for expression of ER46 in human endometrium and 70 decidua of early pregnancy. We describe a mechanism for regulating the function of human 71 uNK cells via expression of ER46 and demonstrate that selective targeting with E2-BSA 72 regulates uNK cell motility. These novel findings identify a role for ER46 in human 73 endometrium and provide unique insight into the importance of membrane-initiated signalling 74 in modulating the impact of E2 on uNK cell function in women. 75
Introduction 80
Oestrogens are essential for reproductive function and fertility. They classically mediate their 81 functions by binding to cognate receptors, ERα and ERβ, encoded by the genes ESR1 and 82 ESR2 respectively. Oestrogens act via systemic endocrine signals and via local intracrine 83 action to regulate key functional processes within the endometrium including proliferation, 84 angiogenesis and inflammation (Gibson, et al., 2012 ) that prime the endometrium for 85 establishment and maintenance of pregnancy (Gibson, et al., 2013 , Gibson, et al., 2018 . 86
Oestrogen action is controlled by ligand availability but also via expression and localisation of 87 ER isoforms which are altered in a cell and tissue context-dependent manner. We have 88 previously used qPCR and immunohistochemistry to document stage and cell-specific 89 expression of ERα and ERβ, as well as ERβ splice variant isoforms in human endometrium 90 and decidua of early pregnancy (reviewed in (Gibson, et al., 2012) ). Endometrial ERα 91 expression is greatest in the proliferative phase with decreased expression in the secretory 92 phase and a further reduction in first trimester decidual tissue compared to non-pregnant 93 endometrial tissues (Critchley, et al., 2002 , Milne, et al., 2005 . In those studies we used a 94 mouse monoclonal antibody directed against recombinant human ERα; the epitope for this 95 antibody was not defined but it recognised a protein of 66KDa (consistent with full length wild 96 type ERα) in breast cancer cell homogenates detected by western blot (Chantalat, et al., 2016 ) 97 and detected ERα in both stromal and epithelial cells by immunohistochemistry ( (Bombail, et 98 al., 2008) see figures 4 and 5). In these studies, immunostaining for ERα detected a protein 99 that was exclusively nuclear, consistent with the established functional role of this receptor 100 protein as a ligand-activated transcription factor. 101
The human ESR1 gene exhibits differential promoter usage and alternative splicing which give 102 rise to splice variant isoforms of the receptor protein. ER46 was the first identified splice variant 103 of human ESR1 (initially designated hERα-46; (Flouriot, et al., 2002) ). The ER46 variant is a 104 46kDa protein which lacks the N-terminal 173 amino acids of the full length ERα protein 105 (66KDa, hereafter referred to as ER66) and arises from splicing of exon 1E to exon 2 via the E and F promoters (Flouriot, et al., 2002) . ER46 contains both ligand binding and DNA binding 107 domains and has been reported to bind oestradiol (E2) and to induce expression of oestrogen 108 response element (ERE)-driven reporter genes (Flouriot, et al., 2002) . ER46 and ER66 share 109 identical sequence homology except that the N-terminal 173 amino acids of ER66 are absent 110 in ER46. As all amino acids in ER46 are also present in ER66, there is no specific antibody 111 that can uniquely identify ER46. It is therefore challenging to assess cell-specific patterns of 112 native ER46 protein expression and this has limited our understanding of its functional 113 significance. 114 ER46 and ER66 proteins can be resolved by size using western blotting techniques in 115 combination with ERα-specific antibodies that recognise epitopes in the N-terminus (ER66 116 alone) or C-terminus (ER66 and/or ER46) of the proteins. Using this approach native 117 expression of ER46 has been reported in human endothelial cell lines (Li, et al., 2003) and in 118 human peripheral blood leukocytes (Pierdominici, et al., 2010) . Detailed microscopy studies 119 by Kim et al, using fluorescent tagged fusion protein revealed that ER46 can be detected 120 localised to the plasma membrane in endothelial cells (Kim, et al., 2011) . These studies have 121 also demonstrated that membrane-associated ER46 can mediate rapid responses to 122 oestrogens suggesting this receptor isoform may play a key role in 'non-genomic' or 123 'membrane-initiated' oestrogen receptor signalling (Kim, et al., 2014) . foetal growth restriction, and recurrent pregnancy loss (Bulmer, et al., 2019 , Gaynor, et al., 132 2017 . However, the factors that regulate uNK cell function in both normal and pathological 133 pregnancy remain poorly understood. 134
We have previously shown that isolated human uNK cells are exquisitely sensitive to 135 oestrogens and can be stimulated to increase cell motility (chemokinesis and migration) in 136 response to E2 (Gibson, et al., 2015) . Notably, changes in uNK cell motility in response to E2 137 are rapid, initiated within minutes, and detected within 1 hour of treatment; consistent with a 138 possible non-genomic signalling response (Gibson, et al., 2015) . We demonstrated that uNK 139 cell response to E2 was abrogated in the presence of the ER antagonist ICI 182,780 140 (Fulvestrant) consistent with an ER-dependent mechanism (Gibson, et al., 2015) . We have 141 previously characterised human uNK cells as ERα (ER66)-negative and ERβ-positive by 142 immunohistochemistry and qPCR (Gibson, et al., 2015 , Henderson, et al., 2003 but in those 143 studies we did not consider expression of ER46 or its potential role in rapid responses to 144
oestrogens. 145
In the current study we used qPCR, western blot and multiplex immunohistochemistry to 146 assess expression of ER46, ER66 and ERβ in endometrial tissues and isolated uNK cells. We 147 sought to identify cell populations within the endometrium that express ER46, define cellular 148 localisation of receptor proteins and to investigate a potential functional role for ER46 in 149 mediating oestrogen responses in uNK cells. 150
Material and Methods 151

Human Tissue Samples 152
Human endometrial tissues were obtained from women undergoing surgery for benign 153 gynaecological conditions (n=24) and human decidua samples from women undergoing 154 surgical termination of pregnancy, mean gestation of 10 weeks, (n=30). Local ethical 155 committee approval was granted and written informed patient consent was obtained prior to 156 tissue collection by a dedicated research nurse (Ethical approval held by HODC; 157 LREC/05/51104/12 and LREC/10/51402/59). Tissue samples were fixed in 4% neutral buffered formalin or RNA Save (Geneflow, Staffordshire, UK). Stage of the menstrual cycle 159 was determined histologically by an experienced gynaecological pathologist and by 160 measurement of serum E2 and progesterone levels as previously detailed (Bombail, et al., 161 2008) . Primary human uNK cells were isolated from fresh human first trimester decidua as 162 described previously (Gibson, et al., 2015) . Briefly, decidual tissues (n=18) were minced, 163 digested in collagenase/DNAse and passed through 70 and 40 µm cell strainers. The cell 164 suspension was overlaid on Histopaque 1077 (Sigma-Aldrich, USA) to separate leukocytes. 165 UNK cells isolated by MACS magnetic bead separation using CD3 depletion and CD56 166 selection (Miltenyi Biotech, Germany). 167
Ishikawa (human endometrial adenocarcinoma) cells (ECACC_99040201) which express 168
ER66 were used as a positive control for western blotting and qPCR: cells were cultured 169 according to established protocols (Collins, et al., 2009) . 170
RNA Extraction, cDNA synthesis and Quantitative real time PCR 171
Total RNA was extracted from cell pellets or 20mg of tissue using Tri-Reagent and chloroform 172 and homogenisation using a tissue lyser for 2 minutes at 20Hz (Qiagen). RNA was extracted 173
using RNeasy Mini kit (Qiagen, UK) according to manufacturer's instructions. RNA quantity 174 and purity was confirmed by Nanodrop ND-1000 spectrophotometry (Thermo Scientific) and 175 was standardised to 100ng/µl for all samples. CDNA was synthesised using SuperScript VILO 176 cDNA Synthesis kit (Invitrogen). 177
Quantitative real time PCR (qPCR) was performed with primer sets (Supplemental Table 1 with primary antibodies: mouse anti-ERα 6F11 (1:300); mouse anti-ERα F-10 (1:1000); rabbit 203 anti-ERβ (1:200); and loading controls were mouse anti-β-Tubulin (1:1000); mouse anti-β 204
Actin (1:2000); rabbit anti-β Actin (1:500) respectively (Supplemental Table 2 ). Membranes 205 were washed in PBS containing 0.1% Tween-20, incubated with appropriate species-specific 206 fluorescent-conjugated secondary antibodies (Supplemental Table 3 ) and visualised using 207
Licor Odyssey infrared imaging system (Licor). 208
Immunohistochemistry 209
Tissues were sectioned and subjected to antigen retrieval in 0.01M citrate pH6 and 210 immunohistochemistry performed according to standard methods (Critchley, et al., 2001) .
Sections were incubated overnight with primary antibodies; ERα (F-10), ERα (6F11) or CD56 212 (as detailed in Supplemental Table 2 ) at 4 o C followed by incubation with peroxidase 213 conjugated secondary antibody for 1 hour (Supplemental Table 3 
Live Cell Imaging 239
The chemokinesis of uNK cells was assessed as described previously (Gibson, et al., 2015) . using ImageJ (manual cell tracking plug-in) and chemotaxis and migration tool software (Ibidi). 248
Statistics 249
Statistical analysis was performed using GraphPad Prism. Kruskal-Wallis test with Dunn's 250 multiple comparison test was used to determine significance between treatments. Where 251 data were analysed as fold change, significance was tested using one-sample t test with 252 hypothetical mean of 1. Criterion for significance was p<0.05. All data are presented as 253 mean ± SEM. 254
Results 255
Profiling human endometrial tissues reveals distinct patterns of ER isoform expression 256
Due to the overlapping sequence homology between mRNAs encoding full length ERα (ER66) 257 and the truncated splice variant isoform ER46 it is impossible to design oligonucleotide primers 258 that can uniquely distinguish between the two isoforms. In this study we designed primer pairs 259 (see Supplementary Table 1 ) directed against sequences in the N or C-terminal of the receptor 260 and used these to detect mRNAs for either ER66 alone (N-terminal primers) or ER66 and/or 261 ER46 (C-terminal primers). Consistent with data from our previous studies (Critchley, et al., 2002 , Milne, et al., 2005 and those of others (Binder, et al., 2015) mRNAs encoded by ESR1 263 assessed using N-terminal primers were present in endometrial tissue homogenates from 264 proliferative and secretory phase endometrium ( Figure 1A ) and significantly decreased in 265 decidual tissue homogenates (p<0.01). In contrast, mRNA expression of ESR1 assessed 266 using C-terminal primers was detected in all samples and was most abundant in secretory 267 phase endometrium ( Figure 1B) . Consistent with our previous findings (Critchley, et al., 2002) , 268 mRNAs encoded by ESR2 (detected using primers directed against the wild type isoform, 269
ERβ1) were more abundant in secretory phase endometrium and decidua than samples from 270 proliferative phase ( Figure 1C) . 271
We next assessed protein expression of ER46 and ER66 isoforms by performing western 272 blotting using antibodies directed against either the whole receptor (clone 6F11) or an epitope 273 in the C-terminal domain (clone F-10) of ERα. Densitometry measurements confirmed 274 variation in the abundance of ER proteins (Figure 2A and B) ; endometrial tissues expressed 275 all three proteins whereas in decidua ER66 was not detected and expression of ER46 (p<0.05) 276
and ERβ1 (p<0.001) was significantly greater than ER66. A single protein band (~66kDa) was 277 detected in endometrial tissue homogenates using the ERα 6F11 antibody: decidual tissue 278 homogenates had no detectable protein at this size ( Figure 2C and D) . Using the C-terminal-279 specific ERα F-10 antibody, proteins corresponding to both 46kDa and 66kDa were detected 280 in endometrium ( Figure 2C ) but only a 46kDa protein was detectable in decidua ( Figure 2D) . 281
A single 59KDa band corresponding to full length ERβ1 (Critchley, et al., 2002) was detected 282 in all samples ( Figure 2C and D) . 283
Immunostaining of ER isoforms in endometrial tissues 284
Dual immunohistochemistry was performed in endometrial tissues to assess the pattern of 285 expression of proteins recognised by the 6F11 and F-10 ERα antibodies. Expression of ER46 286 was inferred from the presence of staining using the C-terminal ERα F-10 antibody and 287 absence of staining with the ERα 6F11 antibody. In proliferative phase endometrium ( Figure  288 3), ERα was detected with both the ERα 6F11 antibody (green) and C-terminal ERα F-10 antibody (red). Consistent with our previous findings (Bombail, et al., 2008 , Milne, et al., 2005 , 290 expression of ER66 was detected in nuclei of both stromal and epithelial cells (yellow arrows). 291
In contrast, a divergent pattern of expression was observed in secretory phase tissue ( Figure  292 3; 'secretory'). ER66 detected using the ERα 6F11 antibody (green) was localised exclusively 293 to cell nuclei and detected in all epithelial cells and some stromal cells. Positive staining using 294 the C-terminal ERα F-10 antibody (ER46/66, red) was detected in the nuclei of epithelial and 295 stromal cells and overlapped with ERα 6F11 antibody (yellow arrow). However, C-terminal 296
ERα F-10 antibody (red) also localised to extra-nuclear sites and was detected in the 297 cytoplasm of epithelial and stromal cells (white arrowhead) as well as the membrane of some 298 cells (white arrows). Notably, when protein was localised to the membrane no staining was 299 detectable in the nucleus using either antibody (white arrows). This pattern of expression was 300 most obvious in first trimester decidual tissues which express lower concentrations of ER66 301 ( Figure 1A and Figure 2B ). Cytoplasmic expression of ERα was detected using the C-terminal 302
ERα F-10 antibody (red) in decidualised stromal cells (white arrowhead) and membrane 303 expression was apparent on numerous cells within the stromal compartment (white arrow). 304
Human uNK cells express of ER46 in first trimester decidual tissues 305
As CD56-positive uterine natural killer (uNK) cells are the most abundant leukocyte in first 306 trimester decidual tissues, we investigated whether membrane ERα expression was 307 associated with this cell by performing triple immunohistochemistry using the 6F11 and ERα 308 F-10 antibodies and anti-CD56 (Figure 4 ). Co-staining of ERα 6F11 antibody (green) 309 confirmed our previous finding that CD56-positive cells (blue) were ER66-negative (Figure 4) . 310
In contrast, ERα was detected on the membranes of uNK cells using the C-terminal ERα F-10 311 antibody (red): this co-expression is visible as pink staining on the surface of uNK cells (white 312 arrows; Figure 4) . 313
Expression of ER46 in isolated human uNK cells 314
UNK cells were isolated from decidua by magnetic sorting and expression of ER66, ER46 and 315 ERβ1 was assessed by qPCR, western blot and immunocytochemistry ( Figure 5 ). Consistent with our previous studies, mRNAs detected using N-terminal primers (ER66) were significantly 317 lower in uNK cells than Ishikawa cells (p<0.0001), in contrast, mRNAs detected using C-318 terminal-specific primers were significantly higher in uNK cells ( Figure 5A ; p<0.05). Expression 319 of ER46 in isolated uNK cells was confirmed by western blot ( Figure 5B ) and 320 immunofluorescence with staining localised to the cell membrane ( Figure 5C ). Consistent with 321 our previous findings, uNK cells contained mRNAs encoded by ESR2 as well as protein of 322 59KDa on western blots corresponding to full length ERβ1 protein ( Figure 5A and B) . 323
ER46 expression in uNK cells promotes membrane-initiated changes in cell motility 324
We have previously demonstrated that treatment of isolated uNK cells with E2 results in 325 increased rates of cell migration (Gibson, et al., 2015) . Based on receptor expression profiling 326 described above, we investigated whether the impact of E2 on uNK cells could be mediated 327 by ER46 (membrane) or ERβ (nucleus). Cells were treated with E2 conjugated to BSA (E2-328 BSA) which cannot cross the cell membrane and would putatively activate ER46, the ERβ-329 selective agonist DPN or to vehicle control (DMSO). We performed live cell imaging of uNK 330 cells using time-lapse microscopy and assessed cell motility. E2-BSA significantly increased 331 uNK cell velocity compared to both DMSO (p<0.0001) and DPN (p<0.001) ( Figure 5D ). Mean 332 velocity of DPN-treated cells was slightly greater than DMSO, but this was not statistically 333 significant. Similarly, E2-BSA significantly increased the accumulated distance of uNK cells 334 compared to both DMSO (p<0.000 1) and DPN (p<0.001) ( Figure 5E ). DPN did not have an 335 independent effect on uNK cell accumulated distance within 2 hours of incubation. 336
Discussion 338
Oestrogens are essential regulators of endometrial function and fertility. Expression of the ER 339 splice variant ER46 has been demonstrated in peripheral blood leukocytes and isolated 340 endothelial cells. In the current study, we have shown for the first time that expression of ER46 341 in human endometrium is distinct from that of full length ERα (ER66). Notably, ER46 is 342 uniquely expressed on the membrane of uNK cells which are otherwise ER66-negative. 343
Functional analysis of uNK cells demonstrated that targeting of ER46 with E2-BSA increased 344 cell motility via rapid, putatively non-genomic mechanisms. 345
Expression of ER46 has not previously been described in human endometrial tissues however 346 by using antibodies able to distinguish between this variant and full length ER66 we identified 347 ER46 protein in tissue homogenates from both cycling (non-pregnant) endometrium as well 348
as first trimester decidua. Previous studies have reported that ER46 acts as a dominant 349 negative repressor of ER66, inhibiting E2-induced transcription of a reporter gene and cell 350 proliferation (Li, et al., 2003 , Penot, et al., 2005 . We suggest expression of ER46 is most 351 likely to impact on classical responses to ER ligands in the endometrium during the growth (Collins, et al., 2009 , Sanderson, et al., 2017 . 362 UNK cells are the predominant leukocyte in secretory endometrium and first trimester decidua 363
where they mature to acquire phenotypic properties that distinguish them from their peripheral blood (pb) NK cell precursors (King, et al., 1991 , King, et al., 1989 , Pace, et al., 1989 . Notably, 365 uNK cells are transcriptionally distinct from pbNK cells (Koopman, et al., 2003) and they exhibit 366 decreased cytotoxicity and increased cytokine secretion compared to pbNK cell subsets. This 367 phenotype is critical to their function and they are essential mediators of vascular remodelling 368 in early pregnancy (Robson, et al., 2012) . Accumulating evidence supports a role for 369 oestrogens in controlling the function of both pbNK precursors and their uNK cell descendants 370 within the endometrium. Human pbNK cells are ER-positive with evidence for ERα and ERβ 371 expression (Pierdominici, et al., 2010) . Profiling of human pbNK cells isolated from different 372 phases of the menstrual cycle demonstrated that pbNK cells exhibit increased adhesion on 373 day 14 (when E2 concentrations peak in the circulation) compared to other phases of the 374 cycle. In the same study, E2 treatment in vitro increased adhesion of pbNK cells to uterine 375 tissues sections (van den Heuvel, et al., 2005) . NK cells play a crucial role in defence against 376 pathogens by carrying out cell-mediated toxicity. This function also appears to be regulated 377 by oestrogens in women as NK cell activity, measured by lytic effector function, is reported to 378 be increased in postmenopausal women (low circulating E2) compared to premenopausal 379 women. Furthermore, NK cell activity is decreased in postmenopausal women following 380 oestrogen hormone replacement therapy (Albrecht, et al., 1996) . This effect is also mirrored 381 in mouse splenic NK cells where E2 is reported to decrease cytotoxic activity (Curran, et al., 382 2001) and their proliferative capacity (Hao, et al., 2008) . Thus, bioavailability of E2 appears to 383 have impacts on homing of pbNK cells to the uterus and also to promote a low cytotoxicity 384 phenotype that is similar to uNK cells. The oestrogen-dominated microenvironment found in 385 the endometrium in early pregnancy is therefore likely to contribute to a similar functional 386 adaptation of uNK cells within the tissue (Gibson, et al., 2013) . 387
We previously demonstrated that incubation with E2 increases uNK cell motility (Gibson, et 388 al., 2015) , attributing the impact of E2 to signalling via ERβ1 as we failed to detect any ERα 389 (ER66) in these cells. However, the changes in uNK cell motility detected in response to E2 390 were rapid (within 1 hour in (Gibson, et al., 2015) ) which prompted us to consider a role for ER46 and membrane-initiated signalling as a mechanism to explain these changes in uNK 392 cell function. Cells which express ER46 may be more likely to transduce oestrogenic 393 responses via cell membrane-initiated pathways. For example, in ER-negative COS7 cells, in 394 which expression of either ER46 or ER66 was induced, ER46 was found to be less efficient at 395 inducing transcription of an ERE-reporter construct than ER66 but more efficient at inducing 396 membrane-initiated phosphorylation of eNOS (Li, et al., 2003) . ER46 has been located to the 397 cell membrane of peripheral blood leukocytes and is reported to be the only ER isoform 398 detected in membrane of pbNK cells (Pierdominici, et al., 2010) . Stimulation of activated 399 human pbNK cells with E2-BSA is reported to increase secretion of interferon-γ (Pierdominici, 400 et al., 2010 ). In the current study we have detected ER46 protein on the cell membrane of 401 decidual uNK cells and found that incubation with E2-BSA, but not the ERβ1-selective agonist 402 DPN, rapidly increased cell motility consistent with ER46 mediating membrane-initiated rapid 403 responses to oestrogens. We have previously demonstrated that oestrone (E1) and E2 are 404 secreted by decidualised stromal cells which may account for accumulation of uNK cells in 405 perivascular areas of the endometrium (Gibson, et al., 2013) where they promote vascular 406 remodelling in early pregnancy (Gibson, et al., 2015 , Robson, et al., 2012 . Changes in uNK 407 cell motility via ER46 may therefore be required for appropriate control of spatiotemporal 408 remodelling during the establishment of pregnancy. 409
It is possible that expression of other ERs such as ER36 (36KDa ER isoform) or G protein-410 coupled ER (GPER) may mediate membrane-initiated responses to oestrogens in endometrial 411 cells as both receptors have been detected at the cell membrane (Thomas, et al., 2005 , Wang, 412 et al., 2005 , Wang, et al., 2006 . However, to the best of our knowledge neither receptor has 413 been detected in uNK cells. Furthermore, ER36 expression has not been reported in the 414 endometrium and the receptor protein lacks both transcriptional activation domains (AF-1 and 415 AF-2) (Wang, et al., 2005) and cannot bind E2 (Lin, et al., 2013) . Whilst GPER has been 416 detected in endometrial tissues its expression appears higher in proliferative than secretory 417 phase or decidua and it has been localised to epithelial cells (Kolkova, et al., 2010 , Plante, et al., 2012 . This pattern contrasts with the abundant expression of ER46 in multiple cell types 419 in endometrium and decidua reported in the current study. Although GPER binds E2 it does 420 not bind other endogenous oestrogens such as E1 or oestriol (E3) (Thomas, et al., 2005) and 421 drugs that inhibit activation of nuclear ERs, including ICI 182,780, function as full agonists to 422 GPER (Prossnitz, et al., 2011) . Given the results in our previous studies demonstrating that 423 both E1 and E2 increase uNK cell migration and that these effects are abrogated by ICI 424 182,780 it is unlikely that GPER is responsible for this rapid change in cell function. 425
Conclusion 426
In the present study we provide new evidence for expression of human ER46 in the 427 endometrium and decidua and highlight a role for this isoform in oestrogenic regulation of uNK 428 cell function. Given the importance of uNK cells to regulating vascular remodelling in early 429 pregnancy and the potential for selective targeting of ER46, this may be an attractive future 430 therapeutic target in the treatment of reproductive disorders. 
